ArticleFrontiers in physiology2016
Cannabinoid CB
Open access · goldAbstract read
In one paragraph
Article in Frontiers in physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
66 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.
- Cys-loop receptors on cannabinoids: All high?Frontiers in physiology · 2022Pooled it
- Endocannabinoid system and skeletal muscle health: Insights from cannabidiol.Molecular metabolism · 2026Review
- Hexahydrocannabinol-induced rhabdomyolysis and acute kidney injury: a case report combining comprehensive toxicokinetic and metabolomic investigations.Journal of cannabis research · 2026Article
- Review
- From localization to function: comparative analysis of CB1 in sperm across species and its epigenetic role in humans.Cell death & disease · 2026Article
- Genetic Tools in Rodents to Study Cannabinoid Functions.Current topics in behavioral neurosciences · 2026Review
- Article
- GPCRs identified on mitochondrial membranes: New therapeutic targets for diseases.Journal of pharmaceutical analysis · 2025Review
- Changes of CB1 Receptor Expression in Tissues of Cocaine-Exposed Eels.Animals : an open access journal from MDPI · 2025Article
- Physiological Muscle Function Is Controlled by the Skeletal Endocannabinoid System in Murine Skeletal Muscles.International journal of molecular sciences · 2025Article
- Methylomic signature of current cannabis use in two first-episode psychosis cohorts.Molecular psychiatry · 2025Article
- Role of the Endocannabinoid System in Fibromyalgia.Current issues in molecular biology · 2025Review
- Quantification of ∆9-tetrahydrocannabinol, 11-OH-THC, THC-COOH, hexahydrocannabinol, and cannabidiol in human plasma and blood by liquid chromatography-tandem mass spectrometry.Journal of analytical toxicology · 2025Article
- Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms.International journal of molecular sciences · 2025Review
- Article
- Comparative transcriptomics of broad-spectrum and synthetic cannabidiol treated C2C12 skeletal myotubes.Physiological reports · 2024Article
- GprC of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells for nematode hunting.Nature microbiology · 2024Article
- Effect of CB1 Receptor Deficiency on Mitochondrial Quality Control Pathways in Gastrocnemius Muscle.Biology · 2024Article
- Cumulative Deleterious Effects of Tetrahydrocannabinoid (THC) and Ethanol on Mitochondrial Respiration and Reactive Oxygen Species Production Are Enhanced in Old Isolated Cardiac Mitochondria.International journal of molecular sciences · 2024Article
- The impact of cannabinoid receptor 1 absence on mouse liver mitochondria homeostasis: insight into mitochondrial unfolded protein response.Frontiers in cell and developmental biology · 2024Article
6 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 7 institutions in 3 countries.
Juan Mendizabal-ZubiagaDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain.
Su MelserGroup "Endocannabinoids and Neuroadaptation," NeuroCentre Magendie, Institut National de La Santé et de La Recherche Médicale, U81215Bordeaux, France; Group "Endocannabinoids and Neuroadaptation," NeuroCentre Magendie, Université de BordeauxBordeaux, France.
Giovanni BénardGroup "Endocannabinoids and Neuroadaptation," NeuroCentre Magendie, Institut National de La Santé et de La Recherche Médicale, U81215Bordeaux, France; Group "Endocannabinoids and Neuroadaptation," NeuroCentre Magendie, Université de BordeauxBordeaux, France.
Almudena RamosDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain.
Leire RegueroDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain.
Sergio ArrabalUnidad de Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga Málaga, Spain.
Izaskun ElezgaraiDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain.
Inmaculada GerrikagoitiaDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain.
Juan SuarezUnidad de Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga Málaga, Spain.
Fernando Rodríguez De FonsecaUnidad de Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga Málaga, Spain.
Nagore PuenteDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain.
Giovanni MarsicanoGroup "Endocannabinoids and Neuroadaptation," NeuroCentre Magendie, Institut National de La Santé et de La Recherche Médicale, U81215Bordeaux, France; Group "Endocannabinoids and Neuroadaptation," NeuroCentre Magendie, Université de BordeauxBordeaux, France.
Pedro GrandesDepartment of Neurosciences, Faculty of Medicine and Nursing, University of the Basque CountryLeioa, Spain; Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology ParkZamudio, Spain; Division of Medical Sciences, University of VictoriaVictoria, BC, Canada.
Achucarro Basque Center for Neuroscience · ESEuskadiko Parke Teknologikoa · ESInstituto de Investigación Biomédica de Málaga · ESUniversité de Bordeaux · FRHospital Regional Universitario de Málaga · ESNeurocentre Magendie · FRUniversity of the Basque Country · ES
Funding
European Research Council 260515
Abstract
The cannabinoid type 1 (CB
Indexed as
endocannabinoid systemimmunocytochemistryintracellular receptorsmetabolismmitochondrial respirationstriated muscle
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.